Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 April 2004, Vol. 103, No. 8, pp. 3216-3221.
Prepublished online as a Blood First Edition Paper on December 30, 2003; DOI 10.1182/blood-2003-08-2860.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2003-08-2860v1
103/8/3216    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cozen, W.
Right arrow Articles by Mack, T. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cozen, W.
Right arrow Articles by Mack, T. M
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted August 20, 2003
Accepted December 11, 2003

IL-6 Levels and Genotype are Associated with Risk of Young Adult Hodgkin Lymphoma

Wendy Cozen*, Parkash S Gill, Sue A Ingles, Rizwan Masood, Otoniel Martinez-Maza, Myles G Cockburn, W J Gauderman, Malcolm C Pike, Leslie Bernstein, Bharat N Nathwani, Muhammad T Salam, Kathleen L Danley, Wei Wang, Julia Gage, Susan Gundell-Miller, and Thomas M Mack

Preventive Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA, USA; Pathology, University of Southern California Keck School of Medicine, Los Angeles, CA, USA
Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA, USA
Preventive Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA, USA
Pathology, University of Southern California Keck School of Medicine, Los Angeles, CA, USA
Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA

* Corresponding author; email: wcozen{at}usc.edu.

Identical twins of young adult Hodgkin lymphoma cases are much more likely to develop the disease compared to fraternal twins of cases, suggesting a genetic determinant. IL-6 levels are increased in Hodgkin lymphoma patients and are correlated with a poor prognosis. We hypothesized that a heritable abnormality in IL-6 regulation may predispose to young adult Hodgkin lymphoma. We obtained blood specimens from 88 young adult Hodgkin lymphoma cases and their twins, and from 87 matched controls. IL-6 was measured from unstimulated peripheral blood mononuclear cell (PBMC) supernatant with ELISA assays and compared using analysis of covariance. Unaffected identical twins of cases (surrogate cases) had a 68.6% higher IL-6 level compared to matched controls (mean difference = +304.6 pg/ml, p=0.04). Analysis of the IL-6 -174 G>C promoter polymorphism genotypes showed that risk decreased with an increasing number of C alleles (p= 0.01). The CC (low secreting) genotype was associated with a decreased risk of young adult Hodgkin lymphoma relative to the GG (high secreting) genotype (odds ratio, OR= 0.29; p= 0.03). Risk was decreased for nodular sclerosis and other subtypes. Persons with genetically determined lower IL-6 levels may be less susceptible to young adult Hodgkin lymphoma.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

Novel twin study implicates IL-6 in the etiology of young adult Hodgkin lymphoma
James R. Cerhan
Blood 2004 103: 2871-2872. [Full Text] [PDF]



This article has been cited by other articles:


Home page
BloodHome page
W. Cozen, A. S. Hamilton, P. Zhao, M. T. Salam, D. M. Deapen, B. N. Nathwani, L. M. Weiss, and T. M. Mack
A protective role for early oral exposures in the etiology of young adult Hodgkin lymphoma
Blood, November 5, 2009; 114(19): 4014 - 4020.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. J. Biggar, J. S. Johansen, K. E. Smedby, K. Rostgaard, E. T. Chang, H.-O. Adami, B. Glimelius, D. Molin, S. Hamilton-Dutoit, M. Melbye, et al.
Serum YKL-40 and Interleukin 6 Levels in Hodgkin Lymphoma
Clin. Cancer Res., November 1, 2008; 14(21): 6974 - 6978.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
S. Poulain, I. Dervite, X. Leleu, V. Coiteux, P. Duthilleul, and P. Morel
The IL6(-174G/C) polymorphism is a prognostic factor for survival after treatment initiation in Waldenstrom macroglobulinemia patients aged 65 years or less
Haematologica, July 1, 2008; 93(7): 1109 - 1111.
[Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
R. Chandra, E. Villanueva, E. Feketova, G. W. Machiedo, G. Hasko, E. A. Deitch, and Z. Spolarics
Endotoxemia down-regulates bone marrow lymphopoiesis but stimulates myelopoiesis: the effect of G6PD deficiency
J. Leukoc. Biol., June 1, 2008; 83(6): 1541 - 1550.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
W. Cozen, P. S. Gill, M. T. Salam, A. Nieters, R. Masood, M. G. Cockburn, W. J. Gauderman, O. Martinez-Maza, B. N. Nathwani, M. C. Pike, et al.
Interleukin-2, interleukin-12, and interferon-{gamma} levels and risk of young adult Hodgkin lymphoma
Blood, April 1, 2008; 111(7): 3377 - 3382.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
W.-C. Liao, J.-T. Lin, C.-Y. Wu, S.-P. Huang, M.-T. Lin, A. S.-H. Wu, Y.-J. Huang, and M.-S. Wu
Serum Interleukin-6 Level but not Genotype Predicts Survival after Resection in Stages II and III Gastric Carcinoma
Clin. Cancer Res., January 15, 2008; 14(2): 428 - 434.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A.V. Brenner, M.A. Butler, S.S. Wang, A.M. Ruder, N. Rothman, P.A. Schulte, S.J. Chanock, H.A. Fine, M.S. Linet, and P.D. Inskip
Single-nucleotide polymorphisms in selected cytokine genes and risk of adult glioma
Carcinogenesis, December 1, 2007; 28(12): 2543 - 2547.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
S Hohaus, M Giachelia, A Di Febo, M Martini, G Massini, B Vannata, F D'Alo', F Guidi, M Greco, F Pierconti, et al.
Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma
Ann. Onc., August 1, 2007; 18(8): 1376 - 1381.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
C. F. Skibola, J. D. Curry, and A. Nieters
Genetic susceptibility to lymphoma
Haematologica, July 1, 2007; 92(7): 960 - 969.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
R.-O. Casasnovas, N. Mounier, P. Brice, M. Divine, F. Morschhauser, J. Gabarre, J.-Y. Blay, L. Voillat, P. Lederlin, A. Stamatoullas, et al.
Plasma Cytokine and Soluble Receptor Signature Predicts Outcome of Patients With Classical Hodgkin's Lymphoma: A Study From the Groupe d'Etude des Lymphomes de l'Adulte
J. Clin. Oncol., May 1, 2007; 25(13): 1732 - 1740.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. E. Grulich, C. M. Vajdic, and W. Cozen
Altered Immunity as a Risk Factor for Non-Hodgkin Lymphoma
Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 405 - 408.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
T. H.M. Keegan, S. L. Glaser, C. A. Clarke, R. F. Dorfman, R. B. Mann, J. A. DiGiuseppe, E. T. Chang, and R. F. Ambinder
Body Size, Physical Activity, and Risk of Hodgkin's Lymphoma in Women.
Cancer Epidemiol. Biomarkers Prev., June 1, 2006; 15(6): 1095 - 1101.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
C. Grimm, L. Six, C. Tomovski, P. Speiser, E. Joura, R. Zeillinger, G. Sliutz, A. Reinthaller, and L. A. Hefler
A Common Interleukin-6 Promoter Polymorphism in Patients With Vulvar Cancer
Reproductive Sciences, December 1, 2005; 12(8): 617 - 620.
[Abstract] [PDF]


Home page
J. Leukoc. Biol.Home page
H. Bruunsgaard
Physical activity and modulation of systemic low-level inflammation
J. Leukoc. Biol., October 1, 2005; 78(4): 819 - 835.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. Bennermo, C. Held, S. Stemme, C.-G. Ericsson, A. Silveira, F. Green, and P. Tornvall
Genetic Predisposition of the Interleukin-6 Response to Inflammation: Implications for a Variety of Major Diseases?
Clin. Chem., November 1, 2004; 50(11): 2136 - 2140.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2003 by American Society of Hematology         Online ISSN: 1528-0020